[PLX] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
16-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 64.01%
YoY- -103.60%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 17,759 27,018 2,469 2,081 -11,195 1,384 1,122 58.42%
PBT 291 9,781 -15,141 -2,624 -12,419 -8,469 -10,885 -
Tax 180 99 916 -189 -85,260 57 0 -
NP 291 9,781 -15,141 -2,624 72,900 -8,469 -10,885 -
Tax Rate -61.86% -1.01% - - - - - -
Total Cost 17,468 17,237 17,610 4,705 -84,095 9,853 12,007 6.44%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 1.64 36.20 -613.24 -126.09 -651.18 -611.92 -970.14 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 0.02 0.66 -1.08 -0.21 7.31 -0.91 -1.18 -
EPS Diluted 0.02 0.66 -1.04 -0.21 7.31 -0.91 -1.17 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.